A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 4 shares of SRPT stock, worth $511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 5 20.0%
Holding current value
$511
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$124.33 - $156.75 $124 - $156
-1 Reduced 20.0%
4 $0
Q2 2024

Jul 30, 2024

BUY
$113.33 - $163.85 $566 - $819
5 New
5 $0

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.2B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.